Childhood Onset Schizophrenia and Early Onset Schizophrenia Spectrum Disorders

Child and Adolescent Psychiatric Clinics of North America

Volumn 22, Issue 4, 2013, Pages 539-555

  Driver, David I ^a   Gogtay, Nitin ^a   Rapoport, Judith L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Childhood onset schizophrenia; Childhood psychosis; Schizophrenia

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ABNORMAL INVOLUNTARY MOVEMENT SCALE; ATTENTION DEFICIT DISORDER; AUDITORY PROCESSING DISORDER; AUTISM; AUTISM SCREENING QUESTIONNAIRE; BIPOLAR DISORDER; BRIEF PSYCHIATRIC RATING SCALE; BUNNY HAMBURG GLOBAL RATING; CARDIOVASCULAR DISEASE; CHILDHOOD ONSET SCHIZOPHRENIA; CHILDREN GLOBAL IMPRESSION SCALE; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; COMMUNICATION DISORDER; COMORBIDITY; DEPRESSIVE PSYCHOSIS; DIABETES MELLITUS; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DSM-IV-TR; DYSKINESIA; GENERALIZED ANXIETY DISORDER; HALLUCINATION; HUMAN; HYPERPROLACTINEMIA; KIDDIE SADS PRESENT AND LIFETIME VERSION; LANGUAGE DISABILITY; LEARNING DISORDER; MAJOR DEPRESSION; MENTAL INSTABILITY; MOTOR DYSFUNCTION; NEUROIMAGING; OBESITY; OBSESSIVE COMPULSIVE DISORDER; PERCEPTION DISORDER; PHYSICAL EXAMINATION; POSITIVE AND NEGATIVE SYNDROME SCALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; PSYCHOPHARMACOLOGY; PSYCHOSOCIAL CARE; PSYCHOSOCIAL DISORDER; PSYCHOTHERAPY; QUESTIONNAIRE; RARE DISEASE; RATING SCALE; REVIEW; SCHEDULE FOR AFFECTIVE DISORDERS AND SCHIZOPHRENIA; SCHIZOPHRENIA; SIMPSON ANGUS SCALE; SPEECH DISORDER; STRUCTURED INTERVIEW; TREATMENT PLANNING; ADOLESCENT; ADULT; BRAIN; CHILD; COHORT ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; INCIDENCE; MENTAL DISORDERS; NATIONAL HEALTH ORGANIZATION; PATHOLOGY; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRODROMAL SYMPTOM; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; CHILD; CHILD, PRESCHOOL; CLOZAPINE; COHORT STUDIES; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; INCIDENCE; MENTAL DISORDERS; NATIONAL INSTITUTE OF MENTAL HEALTH (U.S.); PRACTICE GUIDELINES AS TOPIC; PRODROMAL SYMPTOMS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; UNITED STATES; YOUNG ADULT;

EID: 84883553086     PISSN: 10564993     EISSN: 15580490     Source Type: Journal    
DOI: 10.1016/j.chc.2013.04.001     Document Type: Review

References (101)

1. Schreier H.A. Hallucinations in nonpsychotic children: more common than we think?. JAm Acad Child Adolesc Psychiatry 1999, 38(5):623-625.
2. Childs B., Scriver C.R. Age at onset and causes of disease. Perspect Biol Med 1986, 29(3 Pt 1):437-460.
3. Kelleher I., Cannon M. Psychotic-like experiences in the general population: characterizing a high-risk group for psychosis. Psychol Med 2011, 41(1):1-6.
4. Kelleher I., Connor D., Clarke M.C., et al. Prevalence of psychotic symptoms in childhood and adolescence: a systematic review and meta-analysis of population-based studies. Psychol Med 2012, 42(9):1857-1863.
5. Werry J.S. Child and adolescent (early onset) schizophrenia: a review in light of DSM-III-R. JAutism Dev Disord 1992, 22(4):601-624.
6. McKenna K., Gordon C.T., Rapoport J.L. Childhood-onset schizophrenia: timely neurobiological research. JAm Acad Child Adolesc Psychiatry 1994, 33(6):771-781.
7. Gordon C.T., Frazier J.A., McKenna K., et al. Childhood-onset schizophrenia: an NIMH study in progress. Schizophr Bull 1994, 20(4):697-712.
8. Gogtay N., Weisinger B., Bakalar J.L., et al. Psychotic symptoms and gray matter deficits in clinical pediatric populations. Schizophr Res 2012, 140(1-3):149-154.
9. Rapoport J.L., Gogtay N. Childhood onset schizophrenia: support for a progressive neurodevelopmental disorder. Int J Dev Neurosci 2011, 29(3):251-258.
10. Nicolson R., Malaspina D., Giedd J.N., et al. Obstetrical complications and childhood-onset schizophrenia. Am J Psychiatry 1999, 156(10):1650-1652.
11. Nicolson R., Giedd J.N., Lenane M., et al. Clinical and neurobiological correlates of cytogenetic abnormalities in childhood-onset schizophrenia. Am J Psychiatry 1999, 156(10):1575-1579.
12. De Hert M., Dobbelaere M., Sheridan E.M., et al. Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice. Eur Psychiatry 2011, 26(3):144-158.
13. Large M., Nielssen O., Slade T., et al. Measurement and reporting of the duration of untreated psychosis. Early Interv Psychiatry 2008, 2(4):201-211.
14. Singh S.P. Outcome measures in early psychosis; relevance of duration of untreated psychosis. Br J Psychiatry Suppl 2007, 50:s58-s63.
15. Black K., Peters L., Rui Q., et al. Duration of untreated psychosis predicts treatment outcome in an early psychosis program. Schizophr Res 2001, 47(2-3):215-222.
16. Done D.J., Crow T.J., Johnstone E.C., et al. Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ 1994, 309(6956):699-703.
17. Jones P., Rodgers B., Murray R., et al. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1994, 344(8934):1398-1402.
18. Rapoport J., Chavez A., Greenstein D., et al. Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited. JAm Acad Child Adolesc Psychiatry 2009, 48(1):10-18.
19. Gupta S., Rajaprabhakaran R., Arndt S., et al. Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia. Schizophr Res 1995, 16(3):189-197.
20. Gupta S., Andreasen N.C., Arndt S., et al. Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. Am J Psychiatry 1995, 152(2):191-196.
21. Gupta S.K., Kunka R.L., Metz A., et al. Effect of alosetron (a new 5-HT3 receptor antagonist) on the pharmacokinetics of haloperidol in schizophrenic patients. JClin Pharmacol 1995, 35(2):202-207.
22. Hollis C. Child and adolescent (juvenile onset) schizophrenia. A case control study of premorbid developmental impairments. Br J Psychiatry 1995, 166(4):489-495.
23. Alaghband-Rad J., McKenna K., Gordon C.T., et al. Childhood-onset schizophrenia: the severity of premorbid course. JAm Acad Child Adolesc Psychiatry 1995, 34(10):1273-1283.
24. Nicolson R., Lenane M., Singaracharlu S., et al. Premorbid speech and language impairments in childhood-onset schizophrenia: association with risk factors. Am J Psychiatry 2000, 157(5):794-800.
25. Asarnow J.R., Ben-Meir S. Children with schizophrenia spectrum and depressive disorders: a comparative study of premorbid adjustment, onset pattern and severity of impairment. JChild Psychol Psychiatry 1988, 29(4):477-488.
26. Russell A., Bott L., Sammons C. The phenomena of schizophrenia occurring in childhood. JAm Acad Child Adolesc Psychiatry 1989, 28:399-407.
27. Watkins J.M., Asarnow R.F., Tanguay P.E. Symptom development in childhood onset schizophrenia. JChild Psychol Psychiatry 1988, 29(6):865-878.
28. Nicolson R., Rapoport J.L. Childhood-onset schizophrenia: rare but worth studying. Biol Psychiatry 1999, 46(10):1418-1428.
29. Kolvin I. Studies in the childhood psychoses. I. Diagnostic criteria and classification. Br J Psychiatry 1971, 118(545):381-384.
30. Association, A.P. Recent Updates to Proposed Revisions for DSM-5. 2012; Recent Updates to Proposed Revisions for DSM-5. Available at: Accessed November 28, 2012. http://www.dsm5.org/Pages/RecentUpdates.aspx.
31. Murphy K.C., Jones L.A., Owen M.J. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999, 56(10):940-945.
32. Arinami T., Ohtsuki T., Takase K., et al. Screening for 22q11 deletions in a schizophrenia population. Schizophr Res 2001, 52(3):167-170.
33. Green T., Gothelf D., Glaser B., et al. Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. JAm Acad Child Adolesc Psychiatry 2009, 48(11):1060-1068.
34. Gochman P., Miller R., Rapoport J.L. Childhood-onset schizophrenia: the challenge of diagnosis. Curr Psychiatry Rep 2011, 13(5):321-322.
35. Lawrie S.M., Abukmeil S.S. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry 1998, 172:110-120.
36. Wright I.C., Rabe-Hesketh S., Woodruff P.W., et al. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 2000, 157(1):16-25.
37. Shenton M.E., Dickey C.C., Frumin M., et al. Areview of MRI findings in schizophrenia. Schizophr Res 2001, 49(1-2):1-52.
38. Pantelis C., Yucel M., Wood S.J., et al. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull 2005, 31(3):672-696.
39. Mathalon D.H., Sullivan E.V., Lim K.O., et al. Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 2001, 58(2):148-157.
40. Gur R.E., Cowell P., Turetsky B.I., et al. Afollow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry 1998, 55(2):145-152.
41. Lieberman J., Chakos M., Wu H., et al. Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry 2001, 49(6):487-499.
42. DeLisi L.E. Regional brain volume change over the life-time course of schizophrenia. JPsychiatr Res 1999, 33(6):535-541.
43. Gogtay N. Cortical brain development in schizophrenia: insights from neuroimaging studies in childhood-onset schizophrenia. Schizophr Bull 2008, 34(1):30-36.
44. Luders E., Narr K.L., Thompson P.M., et al. Mapping cortical gray matter in the young adult brain: effects of gender. Neuroimage 2005, 26(2):493-501.
45. Thompson P.M., Mega M.S., Vidal C., et al. Detecting Disease Specific Patterns of Brain Structure using Cortical Pattern Matching and a Population-Based Probabilistic Brain Atlas, IEEE Conference on Information Processing in Medical Imaging (IPMI), UC Davis 2001. Lecture Notes in Computer Science (LNCS) 2001, vol. 2082:488-501. Springer-Verlag, Berlin, Heidelberg.
46. Thompson P.M., Giedd J.N., Woods R.P., et al. Growth patterns in the developing brain detected by using continuum mechanical tensor maps. Nature 2000, 404(6774):190-193.
47. Gogtay N., Giedd J.N., Lusk L., et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA 2004, 101(21):8174-8179.
48. Greenstein D., Lerch J., Shaw P., et al. Childhood onset schizophrenia: cortical brain abnormalities as young adults. JChild Psychol Psychiatry 2006, 47(10):1003-1012.
49. Gogtay N., Greenstein D., Lenane M., et al. Cortical brain development in nonpsychotic siblings of patients with childhood-onset schizophrenia. Arch Gen Psychiatry 2007, 64(7):772-780.
50. Gogtay N., Sporn A., Clasen L.S., et al. Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses. Arch Gen Psychiatry 2004, 61(1):17-22.
51. Sporn A.L., Greenstein D.K., Gogtay N., et al. Progressive brain volume loss during adolescence in childhood-onset schizophrenia. Am J Psychiatry 2003, 160(12):2181-2189.
52. Gogtay N., Sporn A., Clasen L.S., et al. Structural brain MRI abnormalities in healthy siblings of patients with childhood-onset schizophrenia. Am J Psychiatry 2003, 160(3):569-571.
53. Keshavan M.S., Berger G., Zipursky R.B., et al. Neurobiology of early psychosis. Br J Psychiatry Suppl 2005, 48:s8-s18.
54. Keshavan M.S., Tandon R., Boutros N.N., et al. Schizophrenia, "just the facts": what we know in 2008. Part 3: neurobiology. Schizophr Res 2008, 106(2-3):89-107.
55. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987, 44(7):660-669.
56. Rapoport J.L., Giedd J.N., Gogtay N. Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry 2012, 17(12):1228-1238.
57. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?. JPsychiatr Res 1982, 17(4):319-334.
58. Gogos J.A., Gerber D.J. Schizophrenia susceptibility genes: emergence of positional candidates and future directions. Trends Pharmacol Sci 2006, 27(4):226-233.
59. Miyamoto S., LaMantia A.S., Duncan G.E., et al. Recent advances in the neurobiology of schizophrenia. Mol Interv 2003, 3(1):27-39.
60. Weinberger D.R. The biological basis of schizophrenia: new directions. JClin Psychiatry 1997, 58(Suppl 10):22-27.
61. Sawa A., Snyder S.H. Schizophrenia: diverse approaches to a complex disease. Science 2002, 296(5568):692-695.
62. Kleinman J.E., Law A.J., Lipska B.K., et al. Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains. Biol Psychiatry 2011, 69(2):140-145.
63. Marin O. Interneuron dysfunction in psychiatric disorders. Nat Rev Neurosci 2012, 13(2):107-120.
64. Henn F.A. Dopamine: a marker of psychosis and final common driver of schizophrenia psychosis. Am J Psychiatry 2011, 168(12):1239-1240.
65. Lewis D.A., Gonzalez-Burgos G. Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 2008, 33(1):141-165.
66. Beneyto M., Lewis D.A. Insights into the neurodevelopmental origin of schizophrenia from postmortem studies of prefrontal cortical circuitry. Int J Dev Neurosci 2011, 29(3):295-304.
67. Howes O.D., Bose S.K., Turkheimer F., et al. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry 2011, 168(12):1311-1317.
68. Howes O.D., Kapur S. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr Bull 2009, 35(3):549-562.
69. Tandon R., Keshavan M.S., Nasrallah H.A. Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res 2008, 102(1-3):1-18.
70. Tsuang M.T., Faraone S.V. The case for heterogeneity in the etiology of schizophrenia. Schizophr Res 1995, 17(2):161-175.
71. Walsh T., McClellan J.M., McCarthy S.E., et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320(5875):539-543.
72. Green W.H., Padron-Gayol M., Hardesty A.S., et al. Schizophrenia with childhood onset: a phenomenological study of 38 cases. JAm Acad Child Adolesc Psychiatry 1992, 31(5):968-976.
73. Garralda M.E. Hallucinations in children with conduct and emotional disorders: II. The follow-up study. Psychol Med 1984, 14(3):597-604.
74. Garralda M.E. Hallucinations in children with conduct and emotional disorders: I. The clinical phenomena. Psychol Med 1984, 14(3):589-596.
75. Calderoni D., Wudarsky M., Bhangoo R., et al. Differentiating childhood-onset schizophrenia from psychotic mood disorders. JAm Acad Child Adolesc Psychiatry 2001, 40(10):1190-1196.
76. McKenna K., Gordon C.T., Lenane M., et al. Looking for childhood-onset schizophrenia: the first 71 cases screened. JAm Acad Child Adolesc Psychiatry 1994, 33(5):636-644.
77. Kumra S., Briguglio C., Lenane M., et al. Including children and adolescents with schizophrenia in medication-free research. Am J Psychiatry 1999, 156(7):1065-1068.
78. Kumra S., Jacobsen L.K., Lenane M., et al. "Multidimensionally impaired disorder": is it a variant of very early-onset schizophrenia?. JAm Acad Child Adolesc Psychiatry 1998, 37(1):91-99.
79. Towbin K.E., Dykens E.M., Pearson G.S., et al. Conceptualizing "borderline syndrome of childhood" and "childhood schizophrenia" as a developmental disorder. JAm Acad Child Adolesc Psychiatry 1993, 32(4):775-782.
80. Dahl E.K., Cohen D.J., Provence S. Clinical and multivariate approaches to the nosology of pervasive developmental disorders. JAm Acad Child Psychiatry 1986, 25(2):170-180.
81. Petti T.A., Vela R.M. Borderline disorders of childhood: an overview. JAm Acad Child Adolesc Psychiatry 1990, 29(3):327-337.
82. Van der Gaag R.J., Buitelaar J., Van den Ban E., et al. Acontrolled multivariate chart review of multiple complex developmental disorder. JAm Acad Child Adolesc Psychiatry 1995, 34(8):1096-1106.
83. Cohen D.J., Paul R., Volkmar F.R. Issues in the classification of pervasive and other developmental disorders: toward DSM-IV. JAm Acad Child Psychiatry 1986, 25(2):213-220.
84. Ad-Dab'bagh Y., Greenfield B. Multiple complex developmental disorder: the "multiple and complex" evolution of the "childhood borderline syndrome" construct. JAm Acad Child Adolesc Psychiatry 2001, 40(8):954-964.
85. Nicolson R., Lenane M., Brookner F., et al. Children and adolescents with psychotic disorder not otherwise specified: a 2- to 8-year follow-up study. Compr Psychiatry 2001, 42(4):319-325.
86. Gogtay N., Ordonez A., Herman D.H., et al. Dynamic mapping of cortical development before and after the onset of pediatric bipolar illness. JChild Psychol Psychiatry 2007, 48(9):852-862.
87. Lukianowicz N. Hallucinations in non-psychotic children. Psychiatr Clin (Basel) 1969, 2(6):321-337.
88. Caplan R. Thought disorder in childhood. JAm Acad Child Adolesc Psychiatry 1994, 33(5):605-615.
89. Rothstein A. Hallucinatory phenomena in childhood. A critique of the literature. JAm Acad Child Psychiatry 1981, 20(3):623-635.
90. Abramowicz M. Drugs that cause psychiatric symptoms. Med Lett Drugs Ther 1993, 35:65-70.
91. Davison K. Schizophrenia-like psychoses associated with organic cerebral disorders: a review. Psychiatr Dev 1983, 1(1):1-33.
92. McGee R., Williams S., Poulton R. Hallucinations in nonpsychotic children. JAm Acad Child Adolesc Psychiatry 2000, 39(1):12-13.
93. Lambert T.J., Velakoulis D., Pantelis C. Medical comorbidity in schizophrenia. Med J Aust 2003, 178(Suppl):S67-S70.
94. Colton C.W., Manderscheid R.W. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis 2006, 3(2):A42.
95. Goff D.C., Cather C., Evins A.E., et al. Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. JClin Psychiatry 2005, 66(2):183-194. [quiz: 147, 273-4].
96. Ienciu M., Romosan F., Bredicean C., et al. First episode psychosis and treatment delay-causes and consequences. Psychiatr Danub 2010, 22(4):540-543.
97. Franz L., Carter T., Leiner A.S., et al. Stigma and treatment delay in first-episode psychosis: a grounded theory study. Early Interv Psychiatry 2010, 4(1):47-56.
98. Norman R.M., Mallal A.K., Manchanda R., et al. Does treatment delay predict occupational functioning in first-episode psychosis?. Schizophr Res 2007, 91(1-3):259-262.
99. Compton M.T., Esterberg M.L. Treatment delay in first-episode nonaffective psychosis: a pilot study with African American family members and the theory of planned behavior. Compr Psychiatry 2005, 46(4):291-295.
100. Harrigan S.M., McGorry P.D., Krstev H. Does treatment delay in first-episode psychosis really matter?. Psychol Med 2003, 33(1):97-110.
101. Vera I., Rezende L., Molina V., et al. Clozapine as treatment of first choice in first psychotic episodes. What do we know?. Actas Esp Psiquiatr 2012, 40(5):281-289.